Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 152 (1) , 29-34
- https://doi.org/10.1016/s0021-9150(99)00444-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tissue Factor Pathway Inhibitor Is Expressed by Human Monocyte–Derived MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Development of a method to separate lipoprotein-bound and lipoprotein-depleted tissue factor pathway inhibitor. Measurement of free tissue factor pathway inhibitor activityBlood Coagulation & Fibrinolysis, 1998
- The endothelium in atherothrombotic diseasePublished by Wolters Kluwer Health ,1998
- Tissue factor pathway inhibitor: from unknown coagulation inhibitor to major antithrombotic principleCardiovascular Research, 1997
- Effects of Enalapril on Tissue Factor in Patients With Uncomplicated Acute Myocardial InfarctionThe American Journal of Cardiology, 1996
- Tissue factor pathway inhibitor activity in patients with IDDMDiabetes, 1995
- Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- MARKERS OF ENDOTHELIAL PERTURBATION AND DAMAGERheumatology, 1993
- Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.The Journal of cell biology, 1989
- Factor VII and extrinsic pathway inhibitor in acute coronary diseaseBritish Journal of Haematology, 1989